Patents by Inventor Rasmus Jorgensen

Rasmus Jorgensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic derivatives of interleukin-22
    Patent number: 12226487
    Abstract: The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy.
    Type: Grant
    Filed: April 5, 2024
    Date of Patent: February 18, 2025
    Assignee: Cytoki Pharma ApS
    Inventors: Kristian Sass-Ørum, Rasmus Jørgensen, Sebastian Beck Jørgensen, Henning Thøgersen, Thomas Hoeg-Jensen, Michael Paolo Bastner Sandrini
  • THERAPEUTIC DERIVATIVES OF INTERLEUKIN-22
    Publication number: 20240279297
    Abstract: The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, wherein the IL-22 protein comprises at least one amino acid substitution, and their use in therapy.
    Type: Application
    Filed: May 11, 2022
    Publication date: August 22, 2024
    Inventors: Kristian SASS-ØRUM, Rasmus JØRGENSEN, Sebastian Beck JØRGENSEN, Henning THØGERSEN, Thomas HOEG-JENSEN, Michael Paolo Bastner SANDRINI
  • THERAPEUTIC DERIVATIVES OF INTERLEUKIN-22
    Publication number: 20240252649
    Abstract: The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy.
    Type: Application
    Filed: April 5, 2024
    Publication date: August 1, 2024
    Inventors: Kristian SASS-ØRUM, Rasmus JØRGENSEN, Sebastian Beck JØRGENSEN, Henning THØGERSEN, Thomas HOEG-JENSEN, Michael Paolo Bastner SANDRINI
  • THERAPEUTIC DERIVATIVES OF INTERLEUKIN-22
    Publication number: 20240239855
    Abstract: The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty monoacid covalently attached to an IL-22 protein, and their use in therapy.
    Type: Application
    Filed: May 11, 2022
    Publication date: July 18, 2024
    Inventors: Kristian SASS-ØRUM, Rasmus JØRGENSEN, Sebastian Beck JØRGENSEN, Henning THØGERSEN, Thomas HOEG-JENSEN, Michael Paolo Bastner SANDRINI
  • THERAPEUTIC DERIVATIVES OF INTERLEUKIN-22
    Publication number: 20240108731
    Abstract: The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy.
    Type: Application
    Filed: June 30, 2023
    Publication date: April 4, 2024
    Inventors: Kristian SASS-ØRUM, Rasmus JØRGENSEN, Sebastian Beck JØRGENSEN, Henning THØGERSEN, Thomas HOEG-JENSEN, Michael Paolo Bastner SANDRINI
  • THERAPEUTIC DERIVATIVES OF INTERLEUKIN-22
    Publication number: 20230381320
    Abstract: The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy.
    Type: Application
    Filed: June 30, 2023
    Publication date: November 30, 2023
    Inventors: Kristian SASS-ØRUM, Rasmus JØRGENSEN, Sebastian Beck JØRGENSEN, Henning THØGERSEN, Thomas HOEG-JENSEN, Michael Paolo Bastner SANDRINI
  • Therapeutic derivatives of interleukin-22
    Patent number: 11806403
    Abstract: The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy.
    Type: Grant
    Filed: May 5, 2022
    Date of Patent: November 7, 2023
    Assignee: CytoKi Pharma ApS
    Inventors: Kristian Sass-Ørum, Rasmus Jørgensen, Sebastian Beck Jørgensen, Henning Thøgersen, Thomas Hoeg-Jensen, Michael Paolo Bastner Sandrini
  • Therapeutic Derivatives of Interleukin-22
    Publication number: 20220347304
    Abstract: The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy.
    Type: Application
    Filed: May 5, 2022
    Publication date: November 3, 2022
    Inventors: Kristian SASS-ØRUM, Rasmus Jørgensen, Sebastian Beck Jørgensen, Henning Thøgersen, Thomas Hoeg-Jensen, Michael Paolo Bastner Sandrini
  • LONG-ACTING Y2 RECEPTOR AGONISTS
    Publication number: 20130040877
    Abstract: The present invention relates to PYY analogues or derivatives thereof comprising at least one alteration selected from the group consisting of substitutions, insertions, deletions and modifications and optionally a serum albumin binding side chain comprising an alkyl chain with at least 14 carbon atoms. Moreover, the invention relates to compositions hereof and methods of treatment of conditions responsive to Y2 receptor modulation.
    Type: Application
    Filed: September 17, 2010
    Publication date: February 14, 2013
    Applicant: Novo Nordisk A/S
    Inventors: Jacob Kofoed, Jorgen Olsen, Soeren Ostergaard, Rasmus Jorgensen
  • Long-Acting Y2 and/or Y4 Receptor Agonists
    Publication number: 20110275559
    Abstract: The present invention relates to a PYY or PP peptide derivative or analogue thereof derivatised with one or more serum albumin binding side chains comprising a dis-tal tetrazole or carboxylic acid group. Moreover, the invention relates to compositions hereof and methods of treatment of conditions responsive to Y receptor modulation.
    Type: Application
    Filed: May 18, 2009
    Publication date: November 10, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Søren Østergaard, Sanne Møller Knudsen, Jane Spetzler, Rasmus Jørgensen, Jacob Kofoed